Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Some skin diseases and their treatments can negatively affect male fertility.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

HIV can cause unusual and severe skin problems that are hard to treat.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

PRP injections improve hair density and thickness in women with hair loss.

FDG PET/CT scans can change cancer treatment plans for dogs.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Horse skin diseases are complex to manage and often require a biopsy for accurate diagnosis and treatment.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Reflectance confocal microscopy helped diagnose and manage a woman's hair loss without needing a biopsy.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Hippocampus sparing whole brain radiation therapy prevents hair loss and preserves cognitive function.